The efficacy of the new pharmacotherapies will allow clinicians to treat obesity towards individualised treatment targets, similar to what is happening with other chronic diseases such as T2D or dyslipidaemia
En la actualidad no sabemos si los agonistas del receptor GLP1 disminuyen la grasa no afectada por el lipedema, la grasa lipedematosa o ambas 12,13
Anti-Aging Effects: Its antioxidant properties combat free radicals, reducing wrinkles and fine lines
A preliminary, randomized, double-blind, placebo-controlled trial of l-carnosine to improve cognition in schizophrenia
The Ozempic label separately lists fatigue among adverse reactions occurring at a frequency greater than 0.4%
Proapoptotic activity of new glutathione S-transferase inhibitors